SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-8 - Securities to be offered to employees in employee benefit plans:
SEC Accession No. 0001193125-24-090909
Filing Date
2024-04-09
Accepted
2024-04-09 16:47:33
Documents
7
Effectiveness Date
2024-04-09

Document Format Files

Seq Description Document Type Size
1 S-8 d813500ds8.htm S-8 61772
2 EX-5.1 d813500dex51.htm EX-5.1 8388
3 EX-23.1 d813500dex231.htm EX-23.1 2079
4 EX-FILING FEES d813500dexfilingfees.htm EX-FILING FEES 23924
5 GRAPHIC g813500g0408112338294.jpg GRAPHIC 2399
6 GRAPHIC g813500g0408112338518.jpg GRAPHIC 3728
7 GRAPHIC g813500g0408112338678.jpg GRAPHIC 3809
  Complete submission text file 0001193125-24-090909.txt   111501
Mailing Address 10578 SCIENCE CENTER DRIVE, SUITE 200 SAN DIEGO CA 92121
Business Address 10578 SCIENCE CENTER DRIVE, SUITE 200 SAN DIEGO CA 92121 (858) 333-5280
Contineum Therapeutics, Inc. (Filer) CIK: 0001855175 (see all company filings)

IRS No.: 271467257 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-8 | Act: 33 | File No.: 333-278580 | Film No.: 24833268
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)